TECMA SOLUTIONS SPA (TCM.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:TCM - IT0005425050 - Common Stock
2.02 EUR
+0.08 (+4.12%)
We assign a fundamental rating of 3 out of 10 to TCM. TCM was compared to 75 industry peers in the Real Estate Management & Development industry. TCM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TCM is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
TCM had negative earnings in the past year.
In the past year TCM had a positive cash flow from operations.
TCM had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TCM reported negative operating cash flow in multiple years.
1.2 Ratios
TCM has a Return On Assets of -15.15%. This is amonst the worse of the industry: TCM underperforms 84.42% of its industry peers.
TCM's Return On Equity of -55.32% is on the low side compared to the rest of the industry. TCM is outperformed by 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.15% | ||
| ROE | -55.32% | ||
| ROIC | N/A |
ROA(3y)-31.18%
ROA(5y)-18.32%
ROE(3y)-80.71%
ROE(5y)-47.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of TCM (78.63%) is better than 67.53% of its industry peers.
In the last couple of years the Gross Margin of TCM has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for TCM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.63% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y0.03%
2. Health
2.1 Basic Checks
TCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TCM has about the same amount of shares outstanding.
TCM has more shares outstanding than it did 5 years ago.
TCM has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.39, we must say that TCM is in the distress zone and has some risk of bankruptcy.
TCM has a Altman-Z score of 0.39. This is in the lower half of the industry: TCM underperforms 75.32% of its industry peers.
TCM has a debt to FCF ratio of 7.22. This is a slightly negative value and a sign of low solvency as TCM would need 7.22 years to pay back of all of its debts.
The Debt to FCF ratio of TCM (7.22) is better than 79.22% of its industry peers.
TCM has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
TCM has a Debt to Equity ratio of 1.64. This is amonst the worse of the industry: TCM underperforms 80.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.64 | ||
| Debt/FCF | 7.22 | ||
| Altman-Z | 0.39 |
ROIC/WACCN/A
WACC6.89%
2.3 Liquidity
TCM has a Current Ratio of 3.27. This indicates that TCM is financially healthy and has no problem in meeting its short term obligations.
TCM has a better Current ratio (3.27) than 79.22% of its industry peers.
A Quick Ratio of 3.27 indicates that TCM has no problem at all paying its short term obligations.
TCM's Quick ratio of 3.27 is amongst the best of the industry. TCM outperforms 84.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.27 | ||
| Quick Ratio | 3.27 |
3. Growth
3.1 Past
TCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.74%, which is quite impressive.
TCM shows a decrease in Revenue. In the last year, the revenue decreased by -0.74%.
Measured over the past years, TCM shows a very strong growth in Revenue. The Revenue has been growing by 26.75% on average per year.
EPS 1Y (TTM)61.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)-0.74%
Revenue growth 3Y11.91%
Revenue growth 5Y26.75%
Sales Q2Q%-5.24%
3.2 Future
TCM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.50% yearly.
Based on estimates for the next years, TCM will show a very negative growth in Revenue. The Revenue will decrease by -12.24% on average per year.
EPS Next Y32.38%
EPS Next 2Y20.7%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue Next Year2.83%
Revenue Next 2Y-16.37%
Revenue Next 3Y-12.24%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TCM. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 9.13, which indicates a very decent valuation of TCM.
Based on the Price/Forward Earnings ratio, TCM is valued cheaply inside the industry as 87.01% of the companies are valued more expensively.
TCM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.13 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCM is valued cheaply inside the industry as 88.31% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TCM is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.28 | ||
| EV/EBITDA | 9.9 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TCM's earnings are expected to grow with 13.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.7%
EPS Next 3Y13.5%
5. Dividend
5.1 Amount
TCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:TCM (12/3/2025, 7:00:00 PM)
2.02
+0.08 (+4.12%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners9.97%
Inst Owner ChangeN/A
Ins Owners43.53%
Ins Owner ChangeN/A
Market Cap17.39M
Revenue(TTM)13.65M
Net Income(TTM)-1.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.13 | ||
| P/S | 1.24 | ||
| P/FCF | 21.28 | ||
| P/OCF | 8 | ||
| P/B | 4.85 | ||
| P/tB | 24.91 | ||
| EV/EBITDA | 9.9 |
EPS(TTM)-0.2
EYN/A
EPS(NY)0.22
Fwd EY10.95%
FCF(TTM)0.09
FCFY4.7%
OCF(TTM)0.25
OCFY12.51%
SpS1.63
BVpS0.42
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.15% | ||
| ROE | -55.32% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.63% | ||
| FCFM | 5.84% |
ROA(3y)-31.18%
ROA(5y)-18.32%
ROE(3y)-80.71%
ROE(5y)-47.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y0.03%
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.64 | ||
| Debt/FCF | 7.22 | ||
| Debt/EBITDA | 3.16 | ||
| Cap/Depr | 33.82% | ||
| Cap/Sales | 9.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 116.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.27 | ||
| Quick Ratio | 3.27 | ||
| Altman-Z | 0.39 |
F-Score6
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)72.79%
Cap/Depr(5y)132.88%
Cap/Sales(3y)29.58%
Cap/Sales(5y)33.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y32.38%
EPS Next 2Y20.7%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.74%
Revenue growth 3Y11.91%
Revenue growth 5Y26.75%
Sales Q2Q%-5.24%
Revenue Next Year2.83%
Revenue Next 2Y-16.37%
Revenue Next 3Y-12.24%
Revenue Next 5YN/A
EBIT growth 1Y71.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.87%
EBIT Next 3Y32.93%
EBIT Next 5YN/A
FCF growth 1Y116.97%
FCF growth 3YN/A
FCF growth 5Y22.2%
OCF growth 1Y179.97%
OCF growth 3YN/A
OCF growth 5Y33.66%
TECMA SOLUTIONS SPA / TCM.MI FAQ
What is the ChartMill fundamental rating of TECMA SOLUTIONS SPA (TCM.MI) stock?
ChartMill assigns a fundamental rating of 3 / 10 to TCM.MI.
What is the valuation status for TCM stock?
ChartMill assigns a valuation rating of 5 / 10 to TECMA SOLUTIONS SPA (TCM.MI). This can be considered as Fairly Valued.
How profitable is TECMA SOLUTIONS SPA (TCM.MI) stock?
TECMA SOLUTIONS SPA (TCM.MI) has a profitability rating of 1 / 10.
How financially healthy is TECMA SOLUTIONS SPA?
The financial health rating of TECMA SOLUTIONS SPA (TCM.MI) is 4 / 10.